Masahiro Mizoguchi Selected Research

Masahiro Mizoguchi Research Topics

Disease

36	Neoplasms (Cancer) 06/2022 - 04/2002
29	Glioblastoma (Glioblastoma Multiforme) 05/2022 - 10/2004
19	Glioma (Gliomas) 01/2022 - 07/2007
10	Astrocytoma (Pilocytic Astrocytoma) 01/2022 - 04/2002
7	Brain Neoplasms (Brain Tumor) 06/2018 - 07/2007
5	Oligodendroglioma 07/2021 - 10/2007
3	Epilepsy (Aura) 01/2021 - 12/2020
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2017 - 01/2014
2	Disease Progression 06/2022 - 03/2022
2	Clinical Deterioration 03/2022 - 01/2017
2	Cysts 01/2020 - 01/2012
2	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 06/2017 - 09/2007
2	Intracranial Vasospasm 08/2015 - 01/2014
2	Meningioma (Meningiomas) 04/2012 - 07/2007
2	Neurilemmoma (Schwannoma) 04/2012 - 07/2007
1	Cerebral Infarction 09/2022
1	Ischemic Stroke 09/2022
1	Thrombosis (Thrombus) 09/2022
1	Stroke (Strokes) 09/2022
1	Temporal Lobe Epilepsy 01/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Cerebellar Neoplasms 01/2021
1	Encephalocele (Encephalocele, Frontal) 01/2021
1	Spinal Dysraphism (Spina Bifida) 01/2021
1	Central Nervous System Neoplasms 12/2020
1	Surgical Wound 11/2020
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2020
1	Cognitive Dysfunction 06/2018
1	Craniopharyngioma (Craniopharyngiomas) 02/2018
1	Ganglioglioma 06/2017
1	Lymphoma (Lymphomas) 07/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2016

Drug/Important Bio-Agent (IBA)

10	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2022 - 12/2013
6	Bevacizumab (Avastin)FDA Link 03/2022 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 04/2008
5	Biological ProductsIBA 01/2021 - 04/2002
5	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2010
5	Messenger RNA (mRNA)IBA 08/2015 - 07/2007
4	Temozolomide (Temodar)FDA LinkGeneric 12/2020 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
3	Pharmaceutical PreparationsIBA 12/2020 - 01/2012
3	Histones (Histone)IBA 12/2020 - 07/2017
3	GadoliniumIBA 12/2019 - 01/2013
3	Vincristine (Oncovin)FDA LinkGeneric 06/2018 - 09/2007
3	Capsules (Microcapsules)IBA 01/2013 - 01/2007
2	Protons (Proton)IBA 01/2022 - 03/2014
2	Genetic Markers (Genetic Marker)IBA 01/2021 - 06/2017
2	hydrogen sulfite (bisulfite)IBA 01/2020 - 02/2011
2	Procarbazine (Matulane)FDA Link 06/2018 - 01/2016
2	NimustineIBA 06/2018 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 07/2007
2	epidermal growth factor receptor VIIIIBA 07/2012 - 12/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 07/2007
1	General AnestheticsIBA 01/2022
1	MucinsIBA 10/2021
1	Carmustine (FIVB)FDA Link 08/2021
1	Circulating Tumor DNAIBA 03/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	baysilon (polydimethylsiloxane)IBA 01/2021
1	ElementsIBA 01/2021
1	Monoclonal AntibodiesIBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 12/2020
1	TitaniumIBA 01/2020
1	RE 102IBA 12/2019
1	Indicators and Reagents (Reagents)IBA 12/2019
1	CateninsIBA 02/2018
1	Contrast MediaIBA 12/2017
1	Kruppel-Like Factor 4IBA 12/2017
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 07/2017
1	Valine (L-Valine)FDA Link 07/2017
1	Arginine (L-Arginine)FDA Link 07/2017
1	Codon (Codons)IBA 07/2017
1	Proto-Oncogene Proteins B-rafIBA 06/2017
1	2,6-dinitrotoluene (DNT)IBA 06/2017
1	Cytidine Triphosphate (CTP)IBA 07/2016
1	Lomustine (CCNU)FDA Link 01/2016
1	ChromatinIBA 10/2015
1	Fibronectins (Fibronectin)IBA 08/2015
1	ElastinIBA 08/2015
1	CollagenIBA 08/2015
1	Tissue Inhibitor of Metalloproteinase-1IBA 08/2015
1	Laminin (Merosin)IBA 08/2015
1	Tissue Inhibitor of Metalloproteinase-2IBA 08/2015

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 06/2022 - 09/2007
7	Craniotomy 01/2022 - 10/2007
6	Therapeutics 01/2021 - 07/2007
6	Radiotherapy 01/2021 - 09/2007
2	Catheters 09/2022 - 11/2020
2	Chemoradiotherapy 09/2021 - 10/2007
2	Electrodes (Electrode) 01/2021 - 01/2021
1	Thrombectomy 09/2022
1	Punctures 09/2022
1	Stents 09/2022
1	Anterior Temporal Lobectomy 01/2022
1	Immunotherapy 01/2021
1	Precision Medicine 01/2021
1	Lab-On-A-Chip Devices 01/2021
1	Neurosurgical Procedures 11/2020
1	Decompressive Craniectomy 01/2020
1	Salvage Therapy 06/2018